ImClone Investigational Site
Greenville, North Carolina 27834
0 studies enrolling now · 2 studies all time
What they study most
Colon Cancer, Colorectal Cancer, Rectal Cancer
Studies at this site
- A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab — Stopped early
- Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed